AKT1 and acute myeloid leukemia: In the current AML model system, the reduced PTEN protein is associated with increased activation of AKT/mTOR/S6K signaling and proliferation, potentially contributing to a predisposition toward leukemogenesis and reduced survival of the PTEN HET mice.